Replies to post #627 on Lexicon Pharmaceuticals Inc (LXRX)

[BooDog]

Nothing new in bioland that's for sure. Excellent news that makes LXRX even more attractive.

Thanks for posting, haven't had a chance to check filings yet this morning.

Sotagliflozin Significantly Reduced Total Cardiovascular Deaths, Heart Failure Hospitalization and Urgent Visits, Achieving Primary Endpoint in Both Studies


http://www.lexpharma.com/media-center/news/760-results-from-soloist-and-scored-outcomes-studies-presented-at-late-breaking-science-session-of-american-heart-association-scientific-sessions-and-published-in-the-new-england-journal-of-medicine